Report copyright - available with funding for vemurafenib. pERC discussed ... · Final Recommendation for Vemurafenib (Zelboraf) for Advanced Melanoma pERC Meeting: March 15, 2012; pERC Reconsideration
Please pass captcha verification before submit form